Press release
Epigenetics Market by Geographical Analysis and Forecast Up to 2019
To maintain their market position and sustain growth, the key players are engaging in the development of innovative molecules and technologies. They are also entering into partnerships with other players for wider market reach.
Download Complete Healthcare Analytical Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=422
Increasing Need for Targeted Therapy for Cancer Patients to Boost Sales of Epigenetic Drugs and Diagnostic Technologies
Cancer is considered to be one of the leading causes of the numerous deaths, with nearly 13% of the total deaths occurring being attributed to cancer annually. According to a report published by World Health Organization, the number of deaths occurring due to cancer is expected to increase by 45% between 2007 and 2030. Thus, the use of epigenetic drugs is in demand for treating oncological conditions and also for the treatment of other diseases such as disorders of the central nervous system.
With the increase in the number of cancer patients worldwide, the need for epigenetic drugs and diagnostic techniques is also increasing as cancer is one of the major applications using epigenetic drugs for therapeutic treatments. Moreover, the increasing development in the applications of epigenetic drugs and investment in research and development activities for innovation of new drugs is also expected to boost the demand for epigenetic drugs and diagnostic technologies.
Genericization of Major Drugs to Cause Minor Slow Down in Sales of Epigenetics Drugs
Three of the four existing epigenetics drugs in the global market saw patent expiry in 2015. As a result of this, the genericized trademark of drugs such as Vidaza, Daocgen, and Zolinza will slow down the market of epigenetics drugs by pulling down their cost. Thus, the sales of these drugs will be substantially affected due to the significant decrease in their prices. According to TMR, due to the availability of new drugs, the impact of genericization will be mild in 2017 and 2018.
Targeted Therapies to Provide Growth Opportunities for Epigenetic Drugs Manufacturers
As epigenetics drugs have the capacity to modulate epigenetic factors, they are being considered as potential candidates for targeted therapies. Targeted therapies show better survival rates and are less toxic. With the development in various tools and technologies, DNMTs and HDACs are being considered as probable targets for therapeutics in treating maladies. Thus, the use of epigenetic drugs in targeted therapies is anticipated to provide potential growth opportunities for manufacturers of epigenetic drugs in the coming years.
The global epigenetics drugs and diagnostic technologies market is estimated to rise at CAGR of 19.4% by 2018. The market was valued at US$3,080.8 mn in the year 2016 and is likely to reach US$4,067.8 mn by the end of 2018. With a CAGR of 18.5%, North America is likely to be the fastest growing region in the global epigenetic drugs and diagnostic technology market and is likely to hold 50% of the global revenue by 2018.
The review is based on the findings of a TMR report titled, “Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018.”
Browse Full Research Report on Epigenetics Drugs and Diagnostic Technologies Market:
http://www.transparencymarketresearch.com/epigenetics-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epigenetics Market by Geographical Analysis and Forecast Up to 2019 here
News-ID: 395726 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Epigenetic
Epigenetics Market - Harnessing the Epigenetic Revolution: Transforming the Futu …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Epigenetics Market.
Epigenetics Market: https://www.growthplusreports.com/report/epigenetics-market/9171
The Epigenetics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Epigenetics market…
Epigenetic Market 2021 | Detailed Report
The Epigenetic research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the Epigenetic industry to…
Epigenetic Market major players New England Biolabs, Inc., Thermo Fisher Scienti …
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
Epigenetic Market to Observe Strong Development by 2016-2026
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the…
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
